SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-21-121910
Filing Date
2021-04-20
Accepted
2021-04-20 07:07:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 DEFA14A d169933ddefa14a.htm DEFA14A 23922
  Complete submission text file 0001193125-21-121910.txt   24971
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 21836279
SIC: 2834 Pharmaceutical Preparations